Results 61 to 70 of about 21,945 (218)
Preclinical development of the quadrivalent meningococcal (ACYW) tetanus toxoid conjugate vaccine, MenQuadfi® [PDF]
, 2022 Richard D. Kensinger +1 more
openalex +1 more source
International Journal of Cancer, Volume 157, Issue 9, Page 1912-1923, 1 November 2025.What's new? While melanoma vaccines have shown therapeutic promise, predicting their clinical benefits is challenged by factors such as delayed response to immunotherapy and scarcity of biomarkers. Here, the authors examined the long‐term efficacy of vaccination with either 4 or 12 class I MHC‐restricted peptides in high‐risk melanoma.
Emily K. Ninmer +3 more
wiley +1 more source
Systemic treatment of immune checkpoint inhibitor‐induced psoriasis: Inference‐based guidance
Journal of the European Academy of Dermatology and Venereology, Volume 39, Issue 11, Page 1881-1894, November 2025.When managing psoriasis, induced or exacerbated by ICI therapy for cancer, there are concerns regarding immunosuppression from systemic agents for the treatment of psoriasis and the potential impact on ICI efficacy. No direct, high‐level evidence exists to address these concerns.
Kim A. Papp +14 more
wiley +1 more source
Trends in neonatal and post-neonatal tetanus admissions at a Nigerian teaching hospital
Journal of Infection in Developing Countries, 2012 Introduction: Tetanus accounts for high morbidity and case fatality rates in developing countries. This study therefore aimed to identify reasons for the persistence of this disease.
Olusola Adetunji Oyedeji +4 more
doaj +1 more source
Pediatric Allergy and Immunology, Volume 36, Issue 11, November 2025.Abstract Background Primary Atopic Disorders (PAD) represent a recently recognized subset of inborn errors of immunity (IEI), characterized by severe atopy driven by genetic mutations leading to dysregulated type 2 immune responses, excessive mast cell activation, and hyper production of IgE.
Fabio Cardinale +46 more
wiley +1 more source
Western Pacific Surveillance and Response, 2013 Maternal or neonatal tetanus causes deaths primarily in Asia and Africa and is usually the result of poor hygiene during delivery. In 2011, three neonatal tetanus cases were investigated in Papua New Guinea, and all three cases were delivered at home by ...
Grace Kariwiga +6 more
doaj +1 more source
Trials For Preparation Of Combined Vaccine Of Equine Influenza, Equine Herpesvirus–1, Rabies Virus And Tetanus Toxoid [PDF]
, 2021 Safaa A. Warda +7 more
openalex +1 more source
Clinical Case Reports, Volume 13, Issue 10, October 2025.ABSTRACT Tetanus is a life‐threatening disease preventable by immunization through vaccines. In resource‐limited settings, its association with other acute infections should be managed cautiously. A 4‐year‐old unvaccinated male was referred from a nearby hospital for better management of severe malaria and probable enteric fever, after presenting there
Christian Damien Tchuisseu Ngapjang +8 more
wiley +1 more source
Bodily distress syndrome after receiving vaccines: A case report
Journal of General and Family Medicine, 2019 A 48‐year‐old woman presented with various symptoms, including widespread body pains, insomnia, palpitations, and shortness of breath, after receiving tetanus toxoid.
Kentaro Iwata, Yoshiaki Katsuda
doaj +1 more source
Clonal analysis of a human antibody response. Quantitation of precursors of antibody-producing cells and generation and characterization of monoclonal IgM, IgG, and IgA to rabies virus. [PDF]
, 1990 We quantitated and characterized the changes in the human B cell repertoire, at the clonal level, before and after immunization with rabies virus. Moreover, we generated 10 monoclonal cell lines producing IgM, IgG, and IgA antibodies to the virus.
Casali, P +6 more
core